General Biotechnology

Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats

In the high-stakes world of pharmaceutical innovation, timing isn’t just everything—it’s the difference between market dominance and missed opportunities. Yet, many companies find themselves caught off guard by the unpredictable wave of Paragraph IV pa…

Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats Read Post »

Uncategorized

Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline

In the fiercely competitive world of biopharma, timing isn’t just everything—it’s the difference between sealing a deal and watching a promising drug languish in the shadows. Yet, many business development teams overlook a critical factor that can make…

Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline Read Post »

Uncategorized

How to use patent expiry intelligence to reach biosimilar manufacturers at the moment their equipment decisions are live — not after they have already been made

In the fiercely competitive world of biosimilars, timing isn’t just everything—it’s the difference between capturing market share early and falling behind. Yet, many pharmaceutical companies and biosimilar manufacturers are missing a critical window: t…

How to use patent expiry intelligence to reach biosimilar manufacturers at the moment their equipment decisions are live — not after they have already been made Read Post »

Uncategorized

Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry

The Hidden Opportunity in the Patent Cliff: How Market Access Vendors Can Turn the Anticipated Loss of Exclusivity into a Strategic Advantage
Imagine this: your team is staring down the barrel of a patent expiration date for a blockbuster drug. The clo…

Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry Read Post »

Biotechblog
Scroll to Top